Cancer stemness markers have been reported in cell populations with elevated CD44 and reduced CD24 expression levels that exhibited the same drug-resistant histopathological features of the derived tumor when injected in mice at very low concentrations [14]. The gene discussed is CD24; the disease is neoplasm.